Knoxville, TNNCT04655170Now EnrollingIRB Ready

COPD Exacerbation Clinical Trial in Knoxville, TN

Access cutting-edge copd exacerbation treatment through this clinical trial at a research site in Knoxville. Study-provided care at no cost to qualified participants.

Sponsored by University of Tennessee Graduate School of Medicine

Quick Self-Assessment

See if you qualify for this Knoxville location

Preparing your pre-screening questions…

Expert Care in Knoxville

Access copd exacerbation specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related copd exacerbation treatment provided free

Apply for This Knoxville Location

Check if you qualify for this copd exacerbation clinical trial in Knoxville, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Knoxville

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Knoxville site if eligible
  4. 4Begin participation

About This COPD Exacerbation Study in Knoxville

The purpose of this study is to assess the feasibility, safety and efficacy of a combination of nebulized Formoterol and Revefenacin among patients hospitalized for AECOPD compared with standard-of-care therapy with nebulized Albuterol and Ipratropium.

Sponsor: University of Tennessee Graduate School of Medicine

Who Can Participate

Inclusion Criteria

Male or Female
≥ 40 years of age
Admitted to the hospital with a primary diagnosis of AECOPD or acute respiratory failure with a secondary diagnosis of COPD
Able to understand and comply with study procedures
Willingness to sign and date an Informed Consent Form

Exclusion Criteria

Patients unable or unwilling to sign an informed consent or cooperate with study procedures
Patients who are hypersensitive to Formoterol or Revefenacin
Patients who are intubated, have tracheotomy, are receiving mechanical ventilation by mask or artificial airway
Patients, in the opinion of the investigators, who are rapidly decompensating and are immediately in need, or will soon need, ventilator support
Patients who, per the investigator, have unstable cardiovascular disease (e.g., uncontrolled, hypertension, unstable angina, recent MI (within 12 weeks), ventricular arrhythmia, or decompensated heart failure)
Patients with a current diagnosis of lung cancer requiring treatment
Patients that test positive for COVID-19
Pulmonary diseases other than COPD, or lobar pneumonia
Patients with acute psychiatric illness deemed significant by the investigator
Patients with a history of glaucoma deemed significant by the investigator
History of urinary retention deemed significant by the investigator 12 Women who are pregnant or breast feeding

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Knoxville?

Yes, this clinical trial (NCT04655170) has an active research site in Knoxville, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

COPD Exacerbation Treatment Options in Knoxville, TN

If you're searching for copd exacerbation treatment options in Knoxville, TN, this clinical trial (NCT04655170) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Knoxville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced copd exacerbation specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all copd exacerbation clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Knoxville, TN

See all parkinsons disease clinical trials recruiting in Knoxville — not just this study.

Browse Parkinsons Disease Trials in Knoxville →

Browse More Trials by Condition

Parkinsons Disease TrialsCOPD TrialsAll Conditions →

Ready to Join in Knoxville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Knoxville, TN